BIS Research Study Highlights the Global Bioengineered Skin Substitutes Market to Reach $4.33 Billion by 2030

According to a new market intelligence report by BIS Research titled “Global Bioengineered Skin Substitutes Market – Analysis and Forecast, 2020-2030”, the global bioengineered skin substitutes market was valued at $1.31 billion in 2019 and is expected to be $4.33 billion in 2030. The market is expected to grow at a low double-digit compound annual growth rate 2020-2030.
The comprehensive study of the global bioengineered skin substitutes market by BIS Research extensively covers the following:

• Market numbers on micro-segments that are influencing the market growth
• In-depth analysis and markets number for three exclusive segmentation of the market- by Product, by Application, and by End User
• 70+ products offered by key companies of the market and data of 50+ products mapped by product type and by application
• In-depth research on the regulatory scenario and product mapping by four major FDA guidelines and regulatory reforms
• Detailed landscape of cost analysis and supply chain of wound care products
• Detailed global and regional market share analysis including the scrutiny of more than 12+ countries
• Market share analysis for 12+ key public companies and growth share analysis by product and application
• Study of data of 60+ companies

View BIS Research Report : https://bisresearch.com/industry-report/bioengineered-skin-substitutes-market.html

Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and regional analysis. This market intelligence report provides a multidimensional view of the global bioengineered skin substitutes market in terms of market size and growth potential. This research report aims at answering various aspects of the global bioengineered skin substitutes market with the help of the key factors driving the market, threats that can inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.
Furthermore, the competitive landscape chapter in the report presents the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches, partnerships, and product approvals. The research report provides a comprehensive analysis of the product sales, manufacturers, and trend analysis by segment and by region.
Over the past few decades, skin substitutes have evolved progressively targeting chronic wounds such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, as well as acute wounds. These products are progressively being accepted by wound care centers and emergency departments to reduce the length of patient stay and reduce the overall cost of wound management. Currently, there are multiple skin substitutes available in the market, each with different kinds of applications, strengths, and disadvantages that vary depending on the clinical scenario. Each of these products come with their own benefits and are developed either from acellular materials or can be synthesized from autologous, allograft, xenogeneic, or synthetic sources. New advances have been made toward redesigning and remodeling the currently available substitutes to make them user-friendly, commercially affordable, and viable with longer shelf life. With the advancement in tissue engineering, newer procedures are also being developed and adopted to generate skin substitutes for a wider range of clinical applications.

According to Abdul Wahid, Principal Analyst at BIS Research, “North America is the leading contributor to the global bioengineered skin substitutes market. The contribution of North America to the global bioengineered skin substitutes market constituted approximately 45.50% in 2019. The presence of good healthcare infrastructure and large number of well-established wound care centers and hospitals offering wound care services in North America are some of the factors that lead to the dominance of North America in the global bioengineered skin substitutes testing market. By country, North America bioengineered skin substitutes market is largely dominated by the U.S., owing to the favorable government initiatives and regulatory entities alongside the growing adoption and easy accessibility to wound care products and services.”

Request for a Sample: https://bisresearch.com/requestsample?id=1024&type=download

Key insights are drawn from in-depth interviews with the key opinion leaders of more than 20 leading companies, market participants, and vendors. This report is a meticulous compilation of research on more than 15 players in the market ecosystem and profiles 15 companies, including several key players, namely Anika Therapeutics, Inc., AbbVie, Inc., Smith & Nephew plc, Integra LifeSciences Corporation, Boston Scientific Corporation, Organogenesis, Inc., Mölnlycke Health Care AB, Vericel Corporation, Stryker Corporation, Zimmer Biomet, and Aroa Biosurgery, Cook Biotech Incorporated, Promethean LifeSciences, Inc., XCELLentis NV, and AlloSource.

The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.

Who should buy this report?
• Manufacturers of skin substitutes and wound care products
• Wound care service providers and end users of wound care products

How can market intelligence on the global bioengineered skin substitutes market add value to an organization’s decision-making process?
• Aid in wound care product development (specifically skin substitutes) understanding the competitive landscape of the global market
• Help in targeting a segment for launching a new product
• Support in diversifying the product portfolio based on applications: chronic wounds (venous leg ulcer, diabetic foot ulcer, pressure ulcers, other chronic wounds) and acute wounds (surgical and traumatic wounds, and burn injuries)
• Help in analyzing technological substitutes and compare the specification
• Aid in understanding the end-user requirement
• Aid in understanding the regulatory scenario and major healthcare reforms controlling skin substitutes products
• Offer go-to-market strategies by providing inputs related to cost strategies and supply chain of wound care products

Insightful Questions Covered to Enable Companies to Take Strategic Decisions

• What is the importance of bioengineered skin substitutes, and what is their origin?
• What are the different bioengineered skin substitutes products available in the market, and what are their benefits?
• What are the major technological advancements witnessed by the global bioengineered skin substitutes market since 2015, and what is the future scope of the market?
• What are the current key trends of the global bioengineered skin substitutes market, and how is the market evolving?
• What was the market size of the global bioengineered skin substitutes market in 2019, and what is the market size anticipated to be in 2030?
• What is the expected growth rate of the global bioengineered skin substitutes market during the period between 2020 and 2030?
• What is the market scenario and growth potential of different regions of the world, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
• What are the major drivers, challenges, and opportunities of the global bioengineered skin substitutes market?
• What are the major key players of the global bioengineered skin substitutes market?
• How much market share did each of these players occupy in the market in 2019?
• Which companies are anticipated to be highly disruptive in the future, and why?
• What is the regulatory scenario of the global bioengineered skin substitutes market?
• What are the initiatives implemented by different governmental bodies and guidelines put forward by them to regulate the commercialization of bioengineered skin substitutes products?
• What is the supply chain associated with wound care, and what is the cost associated with it?
• What are the key developmental strategies implemented by the key players of the global bioengineered skin substitutes market to sustain the competition of the market?
• What is the percentage share of each of the key players in different key developmental strategies?
• What is the current revenue contribution of the global bioengineered skin substitutes market (by product type), and how is it expected to evolve in the forecast period?
• What is the current revenue contribution of the global bioengineered skin substitutes market (by application type), and how is it expected to evolve in the forecast period?
• What is the current revenue contribution of the global bioengineered skin substitutes market (by end user), and how is it expected to evolve in the forecast period?
• Which region is expected to contribute the highest sales in the global bioengineered skin substitutes market during the period between 2019 and 2030?
• What are the leading countries of different regions that contribute significantly toward the growth of the global bioengineered skin substitutes market?

Contact:
Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch

About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.

Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.

BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.

This release was published on openPR.